Recurrence analysis has emerged as a pivotal framework for understanding the intricate behaviour of complex dynamical systems. By constructing visual representations known as recurrence plots, ...
The role of adjuvant chemotherapy in stage II colon cancer continues to be debated. The presence of circulating tumor DNA (ctDNA) after surgery predicts very poor recurrence-free survival, whereas its ...
Do patients with breast cancer with a low 21-gene recurrence score need regional node irradiation to reduce their risk of locoregional recurrence? Analysis of RxPONDER data suggests only a randomized ...
The presence of circulating tumor DNA (ctDNA) in patients with human epidermal growth factor receptor 2 (HER2)-positive ...
Modified Frailty Index (mFI-5) as a prognostic tool of mortality, complications, and readmissions in patients undergoing hepatic ablation for hepatocellular carcinoma. This is an ASCO Meeting Abstract ...
Recurrence risk for stage II to III colon cancer falls below 0.5% 6 years posttreatment, suggesting a potential cure definition. The study analyzed data from 15 phase 3 trials, involving 35,213 ...
Blue light cystoscopy reduces bladder cancer recurrence risk by 38% compared to white light cystoscopy, as shown in the BRAVO study. The BRAVO study used real-world data from 626 veterans, confirming ...
OSLO, Norway, Dec. 8, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the presentation of a health economics abstract from the BRAVO study at the Society of ...
Machine learning models are designed to analyze large, heterogeneous datasets and identify complex relationships without ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback